CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 985 enrolled
Drug / intervention
Influenza Vaccinebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02290691
NCT02290691Phase 4Completed
CompareCT.gov

Inactivated Influenza Via Jet Injection

PharmaJet, Inc.·interventional·Posted Nov 14, 2014·Updated Nov 30, 2017

In Brief

A Phase 4 clinical trial evaluating Influenza Vaccine for Influenza, Human. Completed, enrolled 985 participants across 6 sites.

Detailed Summary

The purpose of this study is to determine if the administration of flu vaccine using Needle-Free is equivalent to Needle and Syringe administration as measured by laboratory tests of immune response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza, Human
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 14, 2014
Enrollment StartNov 1, 2014
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.6 years ago

Interventions

Influenza Vaccinebiological

Influenza Vaccine